TABLE 4.
Study phase | Drug |
r2 value for drug responses
|
|||||||
---|---|---|---|---|---|---|---|---|---|
CQ | DOX | AQ | AS | DHA | LUM | MFQ | QN | ||
Phase I | CQ | 0.003 | 0.016 | 0.001 | 0.014 | 0.014 | 0.005 | 0.027 | |
DOX | 55 | 0.007 | 0.006 | 0 | 0.008 | 0.011 | 0.016 | ||
AQ | 57 | 49 | 0.097 | 0.1 | 0.079 | 0.047 | 0.02 | ||
AS | 67 | 54 | 56 | 0.728 | 0.27 | 0.267 | 0.219 | ||
DHA | 69 | 56 | 57 | 74 | 0.297 | 0.22 | 0.16 | ||
LUM | 63 | 48 | 50 | 63 | 63 | 0.559 | 0.355 | ||
MFQ | 80 | 55 | 65 | 73 | 76 | 66 | 0.506 | ||
QN | 80 | 59 | 65 | 76 | 78 | 66 | 94 | ||
Phase II | CQ | 0.03 | 0.075 | 0.002 | 0.035 | 0.048 | 0.013 | 0.015 | |
DOX | 161 | 0.033 | 0.001 | 0.051 | 0.037 | 0 | 0 | ||
AQ | 175 | 158 | 0.008 | 0.018 | 0.023 | 0.006 | 0 | ||
AS | 151 | 135 | 152 | 0.383 | 0.16 | 0.334 | 0.152 | ||
DHA | 164 | 145 | 163 | 152 | 0.227 | 0.216 | 0.169 | ||
LUM | 157 | 139 | 149 | 141 | 147 | 0.51 | 0.318 | ||
MFQ | 186 | 162 | 178 | 156 | 169 | 163 | 0.554 | ||
QN | 161 | 164 | 154 | 133 | 145 | 140 | 164 |
Significance of correlations is indicated: bold, P < 0.0001; italic bold, P < 0.001; underline, P < 0.01. Correlations were performed on log-transformed IC50 data.